506690 Share Price Performance
Recent 506690 News & Updates
No updates
Unichem Laboratories Limited Key Details
Last Reported Earnings
Mar 31, 2025
Next Reporting Earnings
Aug 04, 2025
- Earnings per share (EPS)
- 19.53
- Gross Margin
- 56.33%
- Net Profit Margin
- 6.51%
- Debt/Equity Ratio
- 17.5%
Unichem Laboratories Limited Competitors
About 506690
- Founded
- 1944
- Employees
- 3142
- CEO
- WebsiteView website
Unichem Laboratories Limited, a pharmaceutical company, manufactures and sells pharmaceutical products in India, the United States, and internationally. The company offers formulation products that address various therapeutic areas, such as gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterial, anti-infective, and pain management. It also offers active pharmaceutical ingredients, as well as contract manufacturing services. In addition, the company manufactures allopathic medicines, bulk drugs, and chemicals. It serves patients, distributors, health care professionals, and government institutions. The company was founded in 1944 and is based in Mumbai, India. Unichem Laboratories Limited operates as a subsidiary of Ipca Laboratories Ltd.
Indian Market Performance
- 7 Days: -1.6%
- 3 Months: 3.8%
- 1 Year: -6.5%
- Year to Date: -2.0%
Over the last 7 days, the market has dropped 1.6%, driven by a loss of 2.1% in the Financials sector. In the last 12 months the market is down 6.5%. Looking forward, earnings are forecast to grow by 15% annually. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading